Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Professional Societies Collaborate On New Carotid Stent Coverage Request

This article was originally published in The Gray Sheet

Executive Summary

A coalition of professional societies is preparing to ask CMS to reconsider its national Medicare coverage policy on carotid stents and agree to cover the entire FDA-approved indication for the devices, according to the Society for Cardiovascular Angiography and Intervention

You may also be interested in...



Professional Societies Continue To Disagree On Carotid Stent Coverage

Groups pushing for expanded Medicare coverage for carotid stenting are unhappy with a CMS proposal on the matter, and are hoping that interventionalists and surgeons can change the agency's mind by agreeing on which patients are good candidates for the procedure

Professional Societies Continue To Disagree On Carotid Stent Coverage

Groups pushing for expanded Medicare coverage for carotid stenting are unhappy with a CMS proposal on the matter, and are hoping that interventionalists and surgeons can change the agency's mind by agreeing on which patients are good candidates for the procedure

CMS Re-opens Carotid Artery Angioplasty Coverage Decision

CMS is opening another coverage decision on carotid artery angioplasty at the request of physician groups who say the current policy denies adequate medical care to some patients who need the procedure

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025451

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel